Recombinant multi-species CCL16 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCL16 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is one of several cytokine genes clustered on the q-arm of chromosome 17. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for lymphocytes and monocytes but not for neutrophils. This cytokine also shows a potent myelosuppressive activity and suppresses proliferation of myeloid progenitor cells. The expression of this gene is upregulated by IL-10. [provided by RefSeq, Jul 2008]
The Alternative Names of target: CCL16,C-C motif chemokine 16,Chemokine CC-4 (HCC-4), Chemokine LEC, IL-10-inducible chemokine, LCC-1, Liver-expressed chemokine, Lymphocyte and monocyte chemoattractant (LMC), Monotactin-1 (MTN-1), NCC-4, Small-inducible cytokine A16,LEC,LMC,NCC4,CKb12,HCC-4,LCC-1,Mtn-1,NCC-4,SCYL4,ILINCK,SCYA16

Target products collectionGo to CCL16 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0741-Ab-1/ GM-Tg-hg-SE0741-Ab-2 Human CCL16 protein Human
GM-Tg-rg-SE0741-Ab-1/ GM-Tg-rg-SE0741-Ab-2 Rat CCL16 protein Rat
GM-Tg-mg-SE0741-Ab-1/ GM-Tg-mg-SE0741-Ab-2 Mouse CCL16 protein Mouse
GM-Tg-cynog-SE0741-Ab-1/ GM-Tg-cynog-SE0741-Ab-2 Cynomolgus/Rhesus macaque CCL16 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0741-Ab-1/ GM-Tg-felg-SE0741-Ab-2 Feline CCL16 protein Feline
GM-Tg-cang-SE0741-Ab-1/ GM-Tg-cang-SE0741-Ab-2 Canine CCL16 protein Canine
GM-Tg-bovg-SE0741-Ab-1/ GM-Tg-bovg-SE0741-Ab-2 Bovine CCL16 protein Bovine
GM-Tg-equg-SE0741-Ab-1/ GM-Tg-equg-SE0741-Ab-2 Equine CCL16 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0741-Ab-1/ GM-Tg-hg-SE0741-Ab-2; GM-Tg-rg-SE0741-Ab-1/ GM-Tg-rg-SE0741-Ab-2;
GM-Tg-mg-SE0741-Ab-1/ GM-Tg-mg-SE0741-Ab-2; GM-Tg-cynog-SE0741-Ab-1/ GM-Tg-cynog-SE0741-Ab-2;
GM-Tg-felg-SE0741-Ab-1/ GM-Tg-felg-SE0741-Ab-2; GM-Tg-cang-SE0741-Ab-1/ GM-Tg-cang-SE0741-Ab-2;
GM-Tg-bovg-SE0741-Ab-1/ GM-Tg-bovg-SE0741-Ab-2; GM-Tg-equg-SE0741-Ab-1/ GM-Tg-equg-SE0741-Ab-2
Products Name CCL16 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CCL16
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCL16 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.